APLS

Apellis Pharmaceuticals Inc

NASDAQ · Biotechnology

$23.49

+0.93 (+4.12%)

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Buy

28 analysts

Buy 19 68%

Hold 8 29%

Sell 1 4%

Price Target

Analyst Price Target -4.0% upside

Low Target $12.93

Average Target $22.54

High Target $29.12

Current Price $23.49

Current
$23.49

Target
$22.54

$12.93 $22.54 avg $29.12